Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Atherosclerosis|August 18, 2009
Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5aWalter S Speidl, Katharina M Katsaros, Stefan P Kastl, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9Katharina M Katsaros, Stefan P Kastl, Gerlinde Zorn, et al.
Plos One|May 12, 2020
The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitroStefan P Kastl, Katharina M Katsaros, Konstantin A Krychtiuk, et al.
Thrombosis Research|June 19, 2008
Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantationKatharina M Katsaros, Stefan P Kastl, Kurt Huber, et al.
Cytokine|April 15, 2014
An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosisSvitlana Demyanets, Ioannis Tentzeris, Rudolf Jarai, et al.
Atherosclerosis|March 7, 2012
Premature myocardial infarction is associated with low serum levels of Wnt-1Georg Goliasch, Franz Wiesbauer, Stefan P Kastl, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2010
The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitroWalter S Speidl, Stefan P Kastl, Randolph Hutter, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 31, 2013
An increase of VEGF plasma levels is associated with restenosis of drug-eluting stentsKatharina M Katsaros, Stefan P Kastl, Konstantin A Krychtiuk, et al.
Plos One|April 23, 2014
Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcomeSvitlana Demyanets, Walter S Speidl, Ioannis Tentzeris, et al.
Plos One|November 12, 2015
G-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery DiseaseKatharina M Katsaros, Walter S Speidl, Svitlana Demyanets, et al.
Pageof 2